Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2366 (LINC02366)

Target
LINC02366
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2366 (LINC02366) is a human gene that encodes a long non-coding RNA, specifically a long intergenic non-protein coding RNA (lincRNA)[1][3][7]. LincRNAs are a subclass of long non-coding RNAs (>200 nucleotides) that do not overlap protein-coding gene regions and are transcribed from intergenic loci[3][7]. They are often involved in various levels of gene regulation, such as chromatin remodeling, RNA stabilization, and transcriptional regulation; however, as of now, there are no published studies or curated datasets detailing the specific biological function, disease association, or therapeutic potential of LINC02366 itself[1][3].\n\nNotes:\n- LINC02366 is not recognized as a receptor, enzyme, transporter, or established therapeutic target, and no evidence suggests that it interacts with any drugs or serves as a clinical biomarker[1].\n- No alternate names except LINC02366 have been cited; the name itself follows the standard for lincRNA gene naming conventions[1].\n- The entry is not incorrect, but information on its molecular, functional, or clinical relevance is currently very limited and may be updated as research progresses[1][3].

Other names
LINC02366
02

Biological functions

Other (functions of lincRNAs may include chromatin remodeling, gene expression regulation, but specific information for LINC02366 is not available)
03

Disease associations

Other (no direct disease roles identified for LINC02366 as of current knowledge)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2366 (LINC02366).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2366 (LINC02366).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call